Conduit Pharmaceuticals Inc. (NASDAQ:CDT – Get Free Report) was up 0.3% on Friday . The stock traded as high as $3.23 and last traded at $3.00. Approximately 14,194 shares changed hands during mid-day trading, a decline of 59% from the average daily volume of 34,444 shares. The stock had previously closed at $2.99.
Conduit Pharmaceuticals Stock Performance
The business has a 50-day moving average of $3.15 and a two-hundred day moving average of $3.16.
About Conduit Pharmaceuticals
Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.
See Also
- Five stocks we like better than Conduit Pharmaceuticals
- Short Selling: How to Short a Stock
- Appleās Earnings Show Investors Its Strength and Its Weakness
- How to Calculate Return on Investment (ROI)
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- What is a Death Cross in Stocks?
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Conduit Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Conduit Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.